Ranbaxy Reports Corrections At Dewas Plant To FDA; Hopes Import Restrictions Will Be Lifted Soon
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Sobti says Ranbaxy has formally asked FDA for a re-inspection of Dewas and "it will be probably a month or a few months."